• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与因子VIII结合缺陷的血管性血友病变异型:日本首例病例。

Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.

作者信息

Nishino M, Miura S, Yoshioka A, Kuwahara I, Nishimura T, Hamada K, Fukui H

机构信息

Nara Medical College, Department of Pediatrics, Japan.

出版信息

Int J Hematol. 1993 Apr;57(2):163-73.

PMID:8494994
Abstract

This is the first case of variant von Willebrand disease (vWD) with defective binding of von Willebrand factor (vWF) to factor VIII (F.VIII) to be diagnosed in Japan. An 8-year-old Japanese girl, who had had recurrent episodes of subcutaneous hematomas, showed a prolonged A-PTT, low F.VIII (F.VIII:C 4 U/dl, FVIII:Ag 4 U/dl), and normal level of vWF (RCof 80 U/dl, vWF:Ag 60 U/dl). The patient's vWF-multimeric structure on SDS agarose gel electrophoresis was similar to that in normal subjects. A F.VIII binding assay was performed, as described by Nishino et al. (1989). F.VIII binding (y) of vWF was expressed as a function of the amount of immobilized vWF (x) on the wells of a polystyrene plate. Regression lines from normal subjects and the patient had a high correlation coefficient. F.VIII binding capacity was estimated by the slope of the regression lines. The slope for normal subjects showed y = 0.002 + 0.653x, while, in contrast, the slope for the patient showed y = 0.005 + 0.009x, indicating that the capacity of vWF from the patient to bind F.VIII was markedly decreased. Exons 18-20 of the vWF gene, covering the first 132 amino acids of mature vWF subunit from the patient, were sequenced, using the PCR amplification method. A point mutation C-->T at codon 816 in exon 19, predicting a substitution of Trp for Arg(53), was characterized; this was inherited by the patient from her mother.

摘要

这是日本诊断出的首例血管性血友病因子(vWF)与凝血因子VIII(F.VIII)结合缺陷的血管性血友病变异型(vWD)病例。一名8岁日本女孩反复出现皮下血肿,活化部分凝血活酶时间(A-PTT)延长,F.VIII水平低(F.VIII:C 4 U/dl,FVIII:Ag 4 U/dl),vWF水平正常(瑞斯托霉素辅因子活性[RCof] 80 U/dl,vWF:Ag 60 U/dl)。患者vWF在十二烷基硫酸钠琼脂糖凝胶电泳上的多聚体结构与正常受试者相似。按照西野等人(1989年)所述进行F.VIII结合试验。vWF的F.VIII结合(y)表示为聚苯乙烯板孔上固定化vWF量(x)的函数。正常受试者和患者的回归线具有较高的相关系数。通过回归线的斜率估计F.VIII结合能力。正常受试者的斜率显示为y = 0.002 + 0.653x,而相比之下,患者的斜率显示为y = 0.005 + 0.009x,表明患者的vWF结合F.VIII的能力明显降低。使用聚合酶链反应(PCR)扩增方法对患者vWF基因的第18至20外显子进行测序,该外显子涵盖成熟vWF亚基的前132个氨基酸。在外显子19的第816密码子处鉴定出一个点突变C→T,预测色氨酸取代精氨酸(53);这是患者从其母亲那里遗传而来的。

相似文献

1
Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.与因子VIII结合缺陷的血管性血友病变异型:日本首例病例。
Int J Hematol. 1993 Apr;57(2):163-73.
2
Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.血管性血友病因子VIII结合域中Arg91Gln替代的功能分析显示出可变的表型表达。
Thromb Haemost. 1993 Oct 18;70(4):691-6.
3
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
4
New variant of von Willebrand disease with defective binding to factor VIII.血管性血友病因子与凝血因子VIII结合缺陷的血管性血友病新变体。
Blood. 1989 Oct;74(5):1591-9.
5
Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.血管性血友病因子基因第18外显子中鉴定出的两种2N型血管性血友病疾病突变的表达。
Br J Haematol. 2004 Oct;127(2):184-9. doi: 10.1111/j.1365-2141.2004.05187.x.
6
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.1-去氨基-8-D-精氨酸加压素输注后,一名血管性血友病变异型患者的凝血因子VIII:C和血管性血友病因子出现差异增加。
Blood Coagul Fibrinolysis. 1991 Aug;2(4):567-73.
7
Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.在一名因子VIII结合缺陷患者的血管性血友病因子中鉴定出His54Gln替代。
Am J Hematol. 1996 Apr;51(4):302-6. doi: 10.1002/(SICI)1096-8652(199604)51:4<302::AID-AJH9>3.0.CO;2-#.
8
Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.2型诺曼底隐性血管性血友病:轻度血友病和1型血管性血友病的可变表现。
Acta Haematol. 2009;121(2-3):119-27. doi: 10.1159/000214852. Epub 2009 Jun 8.
9
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
10
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.